CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Tea +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02273323
NCT02273323N/ACompleted
CompareCT.gov

Flow Mediated Dilation in Response to Consumption of Black Tea Versus Artificial Tea, in Non-tea Drinking Hypertensive Subjects.

Unilever R&D·interventional·Posted Oct 23, 2014·Updated Feb 15, 2017

In Brief

A clinical study evaluating Tea and Placebo for Vascular Function. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Research indicate that people who regularly drink tea have a reduced risk of stroke or heart disease. In a number of studies in which people that normally do not drink showed that their blood vessels function improved when the drunk tea. The current study tests whether a specific black tea improves vessel function in non-tea drinking hypertensive subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Function
CountriesUnited Kingdom
CollaboratorsKing's College London

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 23, 2014
Enrollment StartOct 1, 2014
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.7 years ago

Interventions

Teaother

Single dose of black tea infusion containing approximately 400 mg flavonoids (expressed as gallic acid equivalents) with added sugar.

Placeboother

Placebo: tea flavour, colouring and sugar